InvestorsHub Logo
Post# of 4972619
Next 10
Followers 1
Posts 326
Boards Moderated 0
Alias Born 12/12/2010

Re: None

Monday, 04/11/2011 8:51:07 PM

Monday, April 11, 2011 8:51:07 PM

Post# of 4972619
PHAR>>>THE NEW 100 LB. GORILLA

here's why:

"AQUAPRIN has no known competition with respect to its pharmacological merits.
And the proprietary technology, trade secrets and “know-how” involved in its
manufacture are unknown to anyone in the industry.
AQUAPRIN is only up against the brand names which have over several decades
entrenched themselves in the minds of consumers. However, after a period of
aggressive marketing, education and consumer recognition, AQUAPRIN should
quickly ascend to the top ranks of the analgesic pantheon.
In Europe, where soluble aspirins dominate, most are fine suspensions, and not
completely dissolved solutions. The majorities are sodium-based, take a few minutes to
dissolve and taste bad, or they are calcium-based, preventing total dissolution of the
aspirin. There is also a French soluble analgesic product, Aspégic; however, it contains
the exotic dl-form of lysine, and could never win FDA approval in the U.S. None of
these foreign products can in any event be marketed in the USA since they do not fall
within any FDA-approved monograph. The only soluble form of aspirin sold in this
country is Alka-Seltzer, which has excessive sodium (1.2 grams per 650 mg. dose), and
cannot be used for chronic pain daily doses or by older people who are on sodium13
restricted diets. It also generates distending amounts of gas. AQUAPRIN is, on the
other hand, a 100% potassium-based, low-effervescence product."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.